ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $14,000 | -66.7% | 4,200 | 0.0% | 0.00% | – |
| Q1 2021 | $42,000 | +250.0% | 4,200 | +2000.0% | 0.00% | – |
| Q4 2020 | $12,000 | +500.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +300.0% | 200 | +100.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 100 | -51.2% | 0.00% | – |
| Q3 2019 | $1,000 | -96.2% | 205 | -90.7% | 0.00% | – |
| Q2 2019 | $26,000 | +116.7% | 2,200 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +71.4% | 2,200 | 0.0% | 0.00% | – |
| Q4 2018 | $7,000 | -46.2% | 2,200 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | +8.3% | 2,200 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | -7.7% | 2,200 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |